TECENTRIQ HYBREZA — GENENTECH INC, approved 2026-05-15 (BLA761347).
23,891 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.